What does the GxP Second Edition include?
The GxP Second Edition provides 676 case-based questions, a seven-domain scorecard, Excel gap-analysis worksheets, PDF implementation checklists, DOCX executive briefings, a remediation roadmap builder, and a 420-page editable playbook - all delivered via email within 24 business hours.
Struggling with fragmented GxP practices that invite audit failures, regulatory fines and licence risk? Without a standards-aligned assessment you cannot prove compliance with PIC/S, FDA 21 CFR Part 211, EU GMP Annex 11 or ICH Q9, and every missed gap increases the chance of product recalls and lost stakeholder confidence. The GxP Second Edition Self-Assessment is the decisive tool that transforms your GxP programme into an audit-ready, continuously improving system - the alternative is costly non-compliance.
What You Receive
- 676 case-based assessment questions (PDF) - covers seven core GxP domains, enabling you to conduct a full maturity evaluation in a single workshop.
- Seven-domain GxP Scorecard framework (XLSX) - weighted scoring rubrics that prioritise gaps, track progress and generate evidence for auditors and senior leadership.
- Gap analysis worksheets (XLSX) - map each finding to the exact regulatory clause, turning assessment results into targeted remediation plans.
- Best-practice implementation checklists (PDF) - ready-to-use checklists for data integrity, change control, deviation management and quality risk management.
- Executive briefing templates (DOCX) - concise briefings to communicate risks, findings and action plans to governance committees and senior management.
- Remediation roadmap builder (XLSX) - step-by-step sequencing tool that aligns corrective actions with risk criticality and resource availability.
- Full 420-page digital playbook (PDF) - fully editable, instantly downloadable and structured for pharmaceutical, biotechnology and medical-device environments.
- README.md and onboarding note (TXT) - quick-start guide delivered by email within 24 business hours.
How This Helps You
- Rapidly identify compliance gaps → reduce audit remediation costs and avoid regulatory fines.
- Demonstrate continuous improvement with a quantifiable scorecard → strengthen stakeholder trust and protect licence status.
- Translate findings into actionable, risk-based roadmaps → accelerate corrective actions and minimise product recall risk.
- Present clear executive briefings → secure leadership buy-in and resource allocation for GxP initiatives.
- Standardised checklists and templates → streamline audit preparation, shorten inspection timelines and maintain product quality.
Who Is This For?
- GxP Compliance Officers responsible for audit readiness.
- Quality Assurance Managers overseeing pharmaceutical, biotech or medical-device programmes.
- Regulatory Affairs Specialists ensuring alignment with FDA, EU GMP and ICH standards.
- Process Improvement Leads tasked with continuous GxP optimisation.
- Senior Executives and Governance Committee members who need concise, data-driven updates on GxP performance.
Choose the GxP Second Edition Self-Assessment now and equip your team with a proven, fully editable toolkit that turns regulatory risk into competitive advantage.